13 results
8-K
EX-99.1
INVA
Innoviva Inc
20 Jan 10
Regulation FD Disclosure
12:00am
also included the hazard ratio in these studies, which again the confidence interval includes 0 for the hazard ratio and the upper bound … of the confidence interval in the hazard ratio is in fact below the 10% non-inferiority margin. So, there is no statistically significant difference in the 28-day
8-K
EX-99.2
INVA
Innoviva Inc
4 Sep 12
Other Events
12:00am
25mcg
(N=820)
(N=806)
(N=811)
(N=818)
Local steroid effects
Lower respiratory tract infections excl. pneumonia
Pneumonia, all recorded
Hazard ratio … (95% CI) for time to 1st pneumonia vs. VI(a)
Fatal pneumonia
1 (<1)
6 (<1)
Hypersensitivity
Bone disorders
Effects on glucose
(a) A hazard
8-K
EX-99.2
INVA
Innoviva Inc
28 Sep 15
Regulation FD Disclosure
12:00am
, hazard ratios).
· UMEC/VI significantly reduced the risk of deteriorations in lung function and SGRQ score in the ITT population versus TIO (Table 3 … )(a)4 unit SGRQ total score increase
HR (95% CI)(a)
Moderate-to-severe COPD exacerbation
HR (95% CI)(a)
*p<0.001; †p=0.045; ‡p=0.004; (a)Hazard
8-K
EX-99.1
INVA
Innoviva Inc
14 Jan 10
Regulation FD Disclosure
12:00am
, 0.018) 0.7584 (N=751) TLV 0.952 0.0161 0.7598 (N=378) VAN 0019+ 1.335 -0.0579 0.7989 (N=374) VAN 0015* Hazard Ratio (TLV/VAN) (95% CI) Difference … 0.0082 0.7605 (N=337) VAN 0019+ 1.172 -0.0303 0.7839 (N=316) VAN 0015* Hazard Ratio (TLV/VAN) (95% CI) Difference TLV-VAN (95% CI) Estimated Kaplan
8-K
EX-99.3
INVA
Innoviva Inc
28 Sep 15
Regulation FD Disclosure
12:00am
to tiotropium 18mcg once daily (hazard ratio: 0.62; 95% confidence interval [CI]: 0.54, 0.71; p<0.001) or placebo (hazard ratio: 0.37; 95% CI: 0.30, 0.45
8-K
EX-99.2
0axsh9sg78vztrma4
20 Jan 10
Regulation FD Disclosure
12:00am
8-K
EX-99.5
zqquaww6h
4 Sep 12
Other Events
12:00am
8-K
EX-99.1
mpff4stnc
4 Sep 12
Other Events
12:00am
8-K
EX-99.1
m660fu 28x
8 Sep 14
Other Events
12:00am
S-1
EX-10.10
nazj8uh 5wz2k
21 Mar 00
IPO registration
12:00am
- Prev
- 1
- Next